STOCK TITAN

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Artivion (NYSE: AORT) will release fourth quarter 2025 financial results on Thursday, February 12, 2026 after market close.

The company will host a teleconference and live webcast at 4:30 p.m. ET with CEO Pat Mackin, followed by Q&A; replay will be available about one hour after the event. Earnings materials and the webcast/replay will be posted in the Investors section at www.artivion.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Key Figures

Results release date: February 12, 2026 Earnings call time: 4:30 p.m. ET Live dial-in: 201-689-8261 +3 more
6 metrics
Results release date February 12, 2026 Fourth quarter 2025 financial results release after market close
Earnings call time 4:30 p.m. ET Teleconference and live webcast start time
Live dial-in 201-689-8261 Number to access the live Q4 2025 teleconference
Replay toll-free 877-660-6853 Toll-free number for teleconference replay
Replay alternate 201-612-7415 Alternate number for teleconference replay
Replay conference ID 13758212 Conference number required to access Q4 2025 replay

Market Reality Check

Price: $40.77 Vol: Volume 283,203 is 1.03x t...
normal vol
$40.77 Last Close
Volume Volume 283,203 is 1.03x the 20-day average of 275,563 shares. normal
Technical Price $41.29 is trading above the 200-day MA at $37.67, near the upper half of its 52-week range.

Peers on Argus

AORT slipped 0.46% with modestly above-average volume while no peers appeared on...

AORT slipped 0.46% with modestly above-average volume while no peers appeared on the momentum scanner and there were no same-day peer headlines flagged.

Previous Conferences,earnings Reports

5 past events · Latest: Oct 23 (Neutral)
Same Type Pattern 5 events
Date Event Sentiment Move Catalyst
Oct 23 Earnings call scheduling Neutral +0.0% Set Q3 2025 results release date and teleconference details.
Jul 24 Earnings call scheduling Neutral +1.1% Announced Q2 2025 results release timing and webcast access.
Apr 21 Earnings call scheduling Neutral +3.3% Outlined Q1 2025 results release date and investor call.
Feb 10 Earnings call scheduling Neutral -0.2% Scheduled Q4 and full-year 2024 results and conference call.
Oct 24 Earnings call scheduling Neutral -0.5% Announced Q3 2024 results release date and webcast logistics.
Pattern Detected

Similar pre-earnings call announcements have typically produced modest, mixed share price moves.

Recent Company History

Over the past year, Artivion has regularly issued releases setting dates and teleconference details for quarterly and full-year results, with calls typically at 4:30 p.m. ET. These announcements around Q1–Q4 2024 and 2025 generally led to small share price moves between about -0.53% and 3.28%. Today’s notice of the planned Q4 2025 results release and call continues this established communications pattern ahead of detailed financial disclosures.

Historical Comparison

conferences,earnings
+1.0 %
Average Historical Move
Historical Analysis

In the past year, Artivion issued 5 similar conferences/earnings scheduling releases, with an average move of 1.03%. Today’s Q4 2025 call notice fits this established pattern of modest reactions.

Typical Pattern

Recurrent quarterly pattern of announcing dates and teleconference details for Q1–Q4 earnings and full-year results in 2024–2025.

Market Pulse Summary

This announcement sets the timetable for Artivion’s fourth quarter 2025 results on February 12, 2026...
Analysis

This announcement sets the timetable for Artivion’s fourth quarter 2025 results on February 12, 2026 and provides teleconference and webcast access details for the 4:30 p.m. ET call. It continues a consistent pattern of quarterly scheduling releases that historically produced modest share moves averaging about 1.03% for this tag. Recent regulatory filings show active insider trading disclosures, with net insider selling of 126,105 shares over the past 90 days, a factor some investors may monitor alongside upcoming earnings details.

AI-generated analysis. Not financial advice.

ATLANTA, Jan. 29, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter 2025 financial results will be released on Thursday, February 12, 2026, after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question-and-answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13758212. 

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:

Artivion

Lance A. Berry

Executive Vice President,
Chief Operating Officer &
Chief Financial Officer
Phone: 770-419-3355

Gilmartin Group LLC

Brian Johnston

Laine Morgan

Phone: 332-895-3222

investors@artivion.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-fourth-quarter-2025-financial-results-302674372.html

SOURCE Artivion, Inc.

FAQ

When will Artivion (AORT) release fourth quarter 2025 results and what time is the call?

Artivion will release fourth quarter 2025 results on February 12, 2026 after market close. According to Artivion, a teleconference and live webcast will start at 4:30 p.m. ET that day, followed by a question-and-answer session.

How can investors join the Artivion (AORT) Q4 2025 teleconference and webcast on February 12, 2026?

Investors can join the live teleconference at 4:30 p.m. ET by dialing 201-689-8261 a few minutes early. According to Artivion, the live webcast and replay are available on the Investors section of www.artivion.com under Webcasts & Presentations.

Will there be a replay of the Artivion (AORT) February 12, 2026 earnings call and how to access it?

A teleconference replay will be available approximately one hour after the event and can be accessed by calling toll-free 877-660-6853. According to Artivion, the webcast replay will also be posted on the company Investors website.

Who will host the Artivion (AORT) Q4 2025 results call and will there be a Q&A session?

The call will be hosted by Pat Mackin, Chairman, President and Chief Executive Officer, and will include a question-and-answer session. According to Artivion, management will address investor questions following prepared remarks.

Where will Artivion (AORT) publish the Q4 2025 earnings press release and related financial information?

Artivion will post the earnings press release and financial/statistical information in the Investors section of www.artivion.com. According to Artivion, the materials will accompany the live webcast and replay for investor access.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

1.91B
43.32M
4.5%
89.88%
2.32%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW